Armata Pharmaceuticals (ARMP) Invested Capital (2018 - 2025)
Armata Pharmaceuticals (ARMP) reported Invested Capital of $48.1 million for Q3 2025, up 16.28% on a YoY basis from $41.4 million in Q3 2024, and up 43.78% sequentially from $33.4 million in Q2 2025.
Armata Pharmaceuticals (ARMP) Invested Capital (2018 - 2025) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 5 years of Invested Capital data on file, last reported at $48.1 million in Q3 2025.
- For the quarter ending Q3 2025, Invested Capital rose 16.28% year-over-year to $48.1 million; the trailing twelve-month figure through Mar 2026 stood at $81.5 million (down 30.5% YoY), and the FY2020 full-year result was $1.9 million, up 100.0% from the prior year.
- Invested Capital rose to $48.1 million in Q3 2025, from $33.4 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $71.7 million in Q1 2024 to a low of $27.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 48.09 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 71.66 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |